This site provides information about Mounjaro ® (tirzepatide) and Zepbound ® (tirzepatide), our prescription-only, FDA-approved medicines containing tirzepatide.

Zepbound contains tirzepatide and should not be used with other tirzepatide-containing products or any GLP-1 receptor agonist medicines. It is not known if Zepbound is safe and effective for …

Zepbound.lilly.com | Please see Indications and Safety Summary with Warnings. Learn how to identify compounded/counterfeit tirzepatide and it's potential risks.

Learn more about Zepbound® (tirzepatide) injection, a treatment for adults with obesity and moderate-to-severe obstructive sleep apnea.

Mounjaro® (tirzepatide) is a once-weekly non-insulin injection for adults to help lower A1C along with diet and exercise. Learn how Mounjaro® works and how to get started.

INDIANAPOLIS, Feb. 25, 2025 /PRNewswire/ -- Today Eli Lilly and Company (NYSE: LLY) announced the launch of 7.5 mg and 10 mg Zepbound (tirzepatide) single-dose vials, available …

Apr 17, 2024 · Tirzepatide achieved a mean apnea-hypopnea index reduction of up to 63% (about 30 fewer events per hour), meeting all primary and key secondary endpoints in two phase 3 …

Mounjaro (tirzepatide) 2.5 mg, 5 mg, 7.5 mg, 10 mg, 12.5 mg, and 15 mg per 0.5 mL injection, is a prescription medicine for adults with type 2 diabetes used along with diet and exercise to …

Search Mounjaro (tirzepatide) injection (type in keywords) Search If you wish to report an adverse event or product complaint, please call 1-800-LILLYRX (1-800-545-5979)

Mounjaro® (tirzepatide) is the first and only, once-weekly approved single-molecule GIP and GLP-1 receptor agonist that helps lower A1C for adults with type 2 diabetes. FOR ADULTS …